AR Degrader-3
AR Degrader-3 is an orally active molecular glue that targets AR/ARV7 and induces the degradation of AR and ARV7 through the ubiquitin-proteasome pathway (UPP). AR Degrader-3 directly interacts with the ligand-binding domain (LBD) and the N-terminal domain (NTD) of AR. AR Degrader-3 effectively suppresses the transcriptional activity of wild-type AR (AR-WT), AR mutants, and ARV7. AR Degrader-3 downregulates the mRNA and protein levels of downstream AR target genes, thereby overcoming antiandrogen resistance mediated by ARV7 and AR point mutations. AR Degrader-3 induces apoptosis in Enzalutamide (HY-70002) (ENZa)-resistant cells and increases cleaved caspase-3 protein levels. AR Degrader-3 can be used for the study of castration-resistant prostate cancer (CRPC).
For research use only. We do not sell to patients.
- CAS No.: 1182011-65-9
- Formula: C23H21N3O4S
- Molecular Weight:435.50
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
|
Caspase-3 |
In Vitro
AR Degrader-3 (Compound A6) (0.2-5 μM, 24 h) broadly inhibits AR transcriptional activity by dose-dependently suppressing both exogenous and endogenous AR in PC-3 and C4-2 cells; additionally, it significantly suppresses endogenous AR and ARV7 in ENZa-resistant 22Rv1 cells, and inhibits the transcriptional activities of AR mutants (W741L, T877A, F876L) in PC-3 cells[1].
AR Degrader-3 (0.078-10 μM, 0-36 h) dose-dependently suppresses ARV7 (DC50 = 0.24 μM) protein level in 22Rv1 cells, powerfully down-regulates AR (DC50 = 0.18 μM) protein level in C4-2 cells, and down-regulates ARV7 protein levels in a time-dependent manner[1].
AR Degrader-3 potently inhibits AR and ARV7 by directly binding to both AR-LBD (IC50 = 105.4 nM) and AR-AF1 (KD = 23.0 μM ) in LNCaP cells[1].
AR Degrader-3 (1-5 μM, 4-8 h) degrades AR and ARV7 through the ubiquitin-proteasome pathway (UPP), as evidenced by its dose-dependent reduction of AR and ARV7 protein but not mRNA levels in C4-2 and 22Rv1 cells, respectively; by demonstrating accelerated degradation upon cycloheximide treatment; by showing that the protein level reduction was counteracted by MG132; and by markedly inducing AR ubiquitination[1].
AR Degrader-3 (72 h) inhibits the proliferation of C4-2 cells (IC50 = 0.59 μM) and 22Rv1 cells (IC50 = 1.4 μM), but has little effect on DU145 (IC50 > 50 μM) and PC-3 (IC50 = 48.6 μM) cells[1].
AR Degrader-3 (0.2-5 μM, 8-24 h) blocks R1881-induced PSA protein expression in a dose-dependent manner and reduces the mRNA levels of PSA and PMEPA1 in 22Rv1 cells[1].
AR Degrader-3 (1-2 μM, 14 days) selectively decreases 22Rv1 cells colony numbers but shows no influence on AR-negative PC-3 cells colony numbers and promotes the apoptosis of the 22Rv1 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:22Rv1 cells
-
Concentration:5 μM
-
Incubation Time:24 h
-
Result:Significantly downregulated the level of ARV7.
-
Cell Line:22Rv1 cells, C4-2 cells
-
Concentration:0.078 μM, 0.156 μM, 0.31 μM, 0.62 μM, 1.25 μM, 2.5 μM, 5 μM, 10 μM
-
Incubation Time:24 h
-
Result:Dose-dependently suppressed ARV7 (DC50 = 0.24 μM) protein level in 22Rv1 cells, down-regulated AR (DC50 = 0.18 μM) protein level in C4-2 cells.
-
Cell Line:22Rv1 cells
-
Concentration:0.2 μM, 1 μM, 5 μM
-
Incubation Time:24 h
-
Result:Blocked R1881-induced PSA protein expression in a dose-dependent manner in 22Rv1 cells.
-
Cell Line:22Rv1 cells
-
Concentration:0.2 μM, 1 μM, 5 μM
-
Incubation Time:8 h
-
Result:Reduced the mRNA level of PSA in 22Rv1 cells.
-
Cell Line:22Rv1 cells
-
Concentration:0.2 μM, 1 μM, 5 μM
-
Incubation Time:24 h
-
Result:Reduced the mRNA level of PMEPA1 in 22Rv1 cells.
-
Cell Line:22Rv1 cells, PC-3 cells
-
Concentration:1 μM, 2 μM
-
Incubation Time:14 days
-
Result:Decreased 22Rv1 cells colony numbers but showed no influence on AR-negative PC-3 cells colony numbers.
Parmacokinetics
| Species | Dose | Route | CL | T1/2 | AUC | Tmax | Cmax | F |
|---|---|---|---|---|---|---|---|---|
| Mice | 1.9 mg/kg | i.v. | 2.17 L/h/kg | 0.73 h | 879 ng·h/mL | / | / | / |
| Mice | 10 mg/kg | p.o. | / | 2.65 h | 657 ng·h/mL | 0.67 h | 178 ng/mL | 13.1 % |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male BALB/c nude mice (5-week-old) were subcutaneously inoculated with 5 × 106 22Rv1 cells[1].
-
Dosage:15 mg/kg, 30 mg/kg
-
Administration:P.o., once daily for 14 days
-
Result:Suppressed 22Rv1 tumor progression.
Showed no change in body weight.
Significantly decreased AR levels in the tumor tissues.
Chemical Information
-
CAS No. 1182011-65-9
-
Molecular Weight 435.50
-
Formula C23H21N3O4S
-
SMILES
CC1=NOC(C)=C1COC2=CC=C(C(NC3=NC(C4=CC=C(OC)C=C4)=CS3)=O)C=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Dual Luciferin reporter gene assay
Luciferin reporter gene assay is a reporting system to detect the activity of Firefly Luciferase using luciferin as a substrate, which is often used in the research of miRNA target gene verification and promoter transcriptive activity regulation. Dual luciferase usually refers to Firefly luciferase and Renilla luciferase.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)